Human Reproduction , 28(10), 2686-2694
reported that treatment of human islets with sitagliptin resulted in a sevenfold increase in islet active GLP-1 content (14), and similarly, in vitro treatment of human islets with linagliptin (114) and vildagliptin (115) has been shown to stabilize active GLP-1 in islet supernatants and protect non-diabetic human islets from experimentally induced beta-cell damage (114)
Cartoon Caption Contest We provide a cartoon, you provide a caption
For detailed comparison of these medication options, see our Zepbound vs Wegovy guide
Mayfield : We do actually have some large victories
France holds a 17.1% share in 2025, expected to maintain 16.9% by 2035, supported by healthcare system demand and pharmaceutical applications, but facing challenges from market competition and healthcare budget considerations